^
CANCER:

Medulloblastoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Medulloblastoma
carmustine
Sensitive
:
A1
No biomarker
Medulloblastoma
cisplatin + cyclophosphamide + vincristine
Sensitive
:
A2
No biomarker
Medulloblastoma
cisplatin + vincristine + lomustine
Sensitive
:
A2
No biomarker
Medulloblastoma
cyclophosphamide
Sensitive
:
A2
No biomarker
Medulloblastoma
vismodegib
Sensitive
:
A2
No biomarker
Medulloblastoma
cisplatin + cyclophosphamide + etoposide IV
Sensitive
:
A2
No biomarker
Medulloblastoma
etoposide oral
Sensitive
:
A2
No biomarker
Medulloblastoma
temozolomide
Sensitive
:
A2
No biomarker
Medulloblastoma
cyclophosphamide + etoposide oral
Sensitive
:
A2
No biomarker
Medulloblastoma
carboplatin + cyclophosphamide + etoposide oral
Sensitive
:
A2
No biomarker
Medulloblastoma
CX-4945
Sensitive
:
B
PTCH1 mutation
Medulloblastoma
vismodegib
Sensitive
:
C3
PTCH1 deletion
Medulloblastoma
IPI 926 oral
Sensitive
:
D
SUFU deletion
Medulloblastoma
sonidegib
Resistant
:
D
MYC expression
Medulloblastoma
JHU395
Sensitive
:
D
SMO D477G
Medulloblastoma
itraconazole
Sensitive
:
D
MYCN amplification
Medulloblastoma
sonidegib
Resistant
:
D
PTCH1 mutation
Medulloblastoma
sonidegib
Sensitive
:
D
SUFU mutation
Medulloblastoma
SMO protein inhibitor
Resistant
:
D
PTCH1 mutation
Medulloblastoma
SMO protein inhibitor
Sensitive
:
D
SMO D473H
Medulloblastoma
vismodegib
Resistant
:
D
SMO D473H
Medulloblastoma
IPI 926 oral
Sensitive
:
D
TP53 mutation
Medulloblastoma
CUDC-907
Sensitive
:
D
TP53 mutation
Medulloblastoma
AN2025 + panobinostat
Sensitive
:
D
TP53 mutation
Medulloblastoma
panobinostat
Sensitive
:
D
TP53 mutation
Medulloblastoma
AN2025
Resistant
:
D
TP53 mutation
Medulloblastoma
AN2025 + sirolimus
Sensitive
:
D
MYC amplification
Medulloblastoma
PCM-075
Sensitive
:
D
MYCN amplification
Medulloblastoma
olaparib + MK-8776
Sensitive
:
D